Are There Any Emerging Therapies Targeting Fluid Accumulation?
Emerging therapies are being developed to target fluid accumulation in cancer patients. Anti-angiogenic drugs, such as bevacizumab, can reduce vascular permeability and fluid buildup. Novel agents targeting the lymphatic system are also under investigation. Additionally, immunotherapy holds potential in modulating the tumor microenvironment and its impact on fluid dynamics.
